Trials / Completed
CompletedNCT04177238
Effects of Oral Fruit Concentrate Supplementation on Cardiometabolic Parameters.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- University of Central Lancashire · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Anthocyanins, found in high quantities in both tart cherries and blueberries are powerful antioxidants, that are potentially capable of improving cardiometabolic dysfunction. However, to date, no research has explored the cardiometabolic responses to tart cherry and blueberry supplementation. Therefore, the primary purpose of the proposed investigation is to test the ability of oral tart cherry and blueberry supplementation to improve cardiometabolic parameters in healthy individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fruit concentrate - either cherry or blueberry | Fruit (cherry or blueberry concentrate) supplement from a company named Active-Edge (https://active-edge.co.uk/). |
Timeline
- Start date
- 2020-01-21
- Primary completion
- 2022-02-05
- Completion
- 2022-08-05
- First posted
- 2019-11-26
- Last updated
- 2022-11-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04177238. Inclusion in this directory is not an endorsement.